🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the effect of timing of food intak...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01575587
Single-arm, single site, open label study of the effects of parenteral test...
Status
Completed
Location
Sibley Memorial Hospital
Start Date
2014-08-25
Trial ID
NCT02090114
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of pembroliz...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2016-11-17
Trial ID
NCT02861573
This is a multi-center phase III study to compare the clinical benefit of a...
Status
Active Not Recruiting
Location
Onze Lieve Vrouw Ziekenhuis
Start Date
2013-11-13
Trial ID
NCT01957436
Treatments Being Tested
This pilot study will explore the prevalence of expression of four immune c...
Status
Completed
Location
Duke University Medical Center
Start Date
2016-11
Trial ID
NCT02456571
Treatments Being Tested
The purpose of the Study is to select a dose and assess the safety and tole...
Status
Terminated
Location
University of Alabama
Start Date
2016-05-18
Trial ID
NCT02711137
Treatments Being Tested
The overall aim of this trial, which is called STAMPEDE, is to assess novel...
Status
Active Not Recruiting
Location
Lausanne Centre Hospitalier Universitaire
Start Date
2005-07-08
Trial ID
NCT00268476
The purpose of this study is to evaluate the relative bioavailability of 4 ...
Status
Completed
Location
Multiple Locations
Start Date
2013-07
Trial ID
NCT01897389
Treatments Being Tested
This is a first-in-human, multi-center, open-label clinical study with sepa...
Status
Completed
Location
David Geffen School of Medicine at UCLA
Start Date
2016-01
Trial ID
NCT02649790
Treatments Being Tested
This is a Phase 1, open-label, dose-escalation and expansion study evaluati...
Status
Terminated
Location
Exelixis Clinical Site #4
Start Date
2021-02-10
Trial ID
NCT04726332
Treatments Being Tested